Publications by authors named "Marat Fudim"

Background: The prevalence of type 2 diabetes (T2D) and obesity are increasing in the United States. However, population-level data for mortality trends due to T2D and obesity are limited. This study aims to assess these death trends among adults in the United States categorized by sex, race, and geographical location.

View Article and Find Full Text PDF

: Patients with postural orthostatic tachycardia syndrome (POTS) or neurogenic orthostatic hypotension (nOH) experience vertigo, confusion, and syncope. Compression garments help reduce venous pooling in these patients, thereby increasing cardiac output. We aimed to determine end-user opinions of compression products intended to alleviate symptoms for POTS and nOH.

View Article and Find Full Text PDF

Pulmonary vein isolation (PVI) has been established as a first-line therapy for symptomatic atrial fibrillation (AF) in selected patients with symptomatic AF and in those whose antiarrhythmic drug treatment failed. However, AF recurrence rates after PVI remain high, prompting the exploration of adjunct therapies, such as renal denervation (RDN), to improve outcomes. This meta-analysis aimed to assess the efficacy of RDN as an adjunct to PVI in reducing AF recurrence.

View Article and Find Full Text PDF

Despite the increasing prevalence and substantial burden of heart failure with preserved ejection fraction (HFpEF), which constitutes up to 50% of all heart failure cases, significant challenges persist in its diagnostic and therapeutic strategies. These difficulties arise primarily from the heterogeneous nature of the condition, the presence of various comorbidities and a wide range of phenotypic variations. Considering these challenges, current international guidelines endorse the utilization of invasive haemodynamic assessments, including resting and exercise haemodynamics, as the gold standard for enhancing diagnostic accuracy in cases where traditional diagnostic methods yield inconclusive results.

View Article and Find Full Text PDF

Background: Invasive exercise right heart catheterization is a gold standard in diagnosing heart failure with preserved ejection fraction (HFpEF). Body positions during the test influence hemodynamics. However, the discrepancy in HFpEF diagnosis between exercise testing in supine versus upright position is unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Nearly half of US adults have obesity, leading to a rise in coronary artery disease (CAD) deaths, which researchers are tracking by age, sex, race, and location.
  • * The study analyzed data from the CDC-WONDER database, revealing that deaths related to CAD and obesity increased from 1999 to 2022, with a significant surge during the COVID-19 pandemic.
  • * Males and non-Hispanic Black individuals experienced higher mortality rates compared to females and other racial groups, and rural areas had higher death rates than urban counterparts.*
View Article and Find Full Text PDF

Heart failure (HF) is a growing concern, with significant implications for mortality, morbidity, and economic sustainability. Traditionally viewed primarily as a hemodynamic disorder, recent insights have redefined HF as a complex systemic syndrome, emphasizing the importance of understanding its multifaceted pathophysiology. Fluid overload and congestion are central features of HF, often leading to clinical deterioration and hospital admissions, with the role of the lymphatic system previously largely overlooked, partly due to diagnostic challenges and visualization difficulties.

View Article and Find Full Text PDF
Article Synopsis
  • Our understanding of how the atria (upper chambers of the heart) work and how they can become dysfunctional (atrial cardiomyopathy) has improved, especially regarding their impact on various heart conditions.
  • Different atrial medical procedures can affect the way the atria function, and it's important for healthcare professionals to be aware of potential negative effects that may not show up right away.
  • By identifying early signs of atrial dysfunction, clinicians can intervene sooner, potentially preventing serious changes in atrial structure and function before they lead to visible health issues.
View Article and Find Full Text PDF
Article Synopsis
  • Heart failure (HF) is increasing worldwide and is a significant strain on healthcare systems, with challenges in preventing symptomatic HF (stage C) and detecting earlier stages (stage B).
  • Machine learning (ML) holds promise for improving HF prevention by enhancing risk prediction, identifying pre-HF signs through diagnostic tests, and analyzing biomarkers, despite some limitations.
  • This review explores how ML can advance HF prevention strategies, its advantages and drawbacks in risk prediction, and possibilities for future applications in managing heart health.
View Article and Find Full Text PDF
Article Synopsis
  • This study evaluated the effectiveness and safety of a new procedure called splanchnic nerve ablation for managing fluid volume in patients with heart failure and preserved ejection fraction (HFpEF).* -
  • Conducted as a phase 2, double-blind, randomized trial involving 90 patients across 15 centers, the study compared the outcomes of the nerve ablation procedure to a sham control.* -
  • Results showed no significant differences in both the primary outcomes (reduction in pulmonary capillary wedge pressure) and safety events between the treatment and control groups, suggesting that the nerve ablation may not provide the expected benefits for these patients.*
View Article and Find Full Text PDF
Article Synopsis
  • A new implantable sensor has been created to measure the area of the inferior vena cava (IVC) to help monitor heart failure (HF) patients daily and predict fluid congestion.
  • The study included 15 HF patients and assessed the sensor's safety, effectiveness, and data transmission, finding high accuracy in IVC measurements and excellent patient adherence to using the device.
  • Results showed that the sensor was safe and effective, with improvements noted in patients' heart failure classification, indicating a need for further research into remote management of heart failure using this technology.
View Article and Find Full Text PDF

The baroreflex system is involved in modulating several physiological functions of the cardiovascular system and can modulate cardiac output, blood pressure, and cardiac electrophysiology directly and indirectly. In addition, it is involved in regulating neurohormonal pathways involved in the cardiovascular function, such as the renin-angiotensin-aldosterone system and vasopressin release. Baroreflex dysfunction is characterized by sympathetic overactivation and parasympathetic withdrawal and is associated with several cardiovascular diseases, such as hypertension, heart failure, and coronary artery disease.

View Article and Find Full Text PDF

Background: There is a need for better noninvasive remote monitoring solutions that prevent hospitalizations through the early prediction and management of heart failure (HF). SurveillanCe and Alert-Based Multiparameter Monitoring to ReducE Worsening Heart Failure Events (SCALE-HF 1) evaluated the performance of a novel congestion index that alerts to fluid accumulation preceding HF events.

Methods And Results: SCALE-HF 1 was a multicenter, prospective, observational study investigating HF event prediction using data from the cardiac scale.

View Article and Find Full Text PDF
Article Synopsis
  • - The SPIRRIT-HFpEF trial aims to evaluate the benefits of mineralocorticoid receptor antagonists (MRAs) like spironolactone for patients with heart failure and preserved or mildly reduced ejection fraction, focusing on a cost-effective registry-based approach.
  • - This multicenter trial involves randomizing patients to receive either MRAs with usual care or just usual care, measuring outcomes such as cardiovascular deaths and heart failure-related hospitalizations over a 6-year enrollment period, with a target of around 2400 patients.
  • - The study’s findings will provide insights into the effectiveness of MRAs for heart failure patients and demonstrate the viability of using pragmatic, registry-based trials for research in chronic conditions.
View Article and Find Full Text PDF

Aims: Quantitative methods have shown clinically significant heterogeneity in blood volume (BV) profiles across heart failure (HF) phenotypes. These profiles extend from hypovolaemia to normal BV and to variable degrees of BV hypervolaemia, frequently with similar clinical presentations. However, a comprehensive survey of BV profiles providing practical clinical guidance for the interpretation and management of quantitative plasma volume (PV) and red blood cell (RBC) mass findings has not been reported.

View Article and Find Full Text PDF

Background: Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) remains underused. Acute heart failure (HF) hospitalization represents a critical opportunity for rapid initiation of evidence-based medications. However, data on GDMT use at discharge are mostly derived from national quality improvement registries.

View Article and Find Full Text PDF
Article Synopsis
  • Heart failure (HF) is a growing health issue with increasing prevalence and mortality, requiring effective treatment strategies.
  • Current foundational therapies for HF include a mix of medications (like ARNIs and SGLTis) and device-based interventions (like ICDs and CRT), though significant risks remain even with treatment.
  • The focus is on enhancing care for HF patients through early diagnosis, personalized treatment plans, and continued research into optimizing the use of emerging device therapies alongside existing pharmacological options.
View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated the effectiveness of stellate ganglion block (SGB) as a treatment for refractory ventricular arrhythmias, focusing on patient characteristics and success predictors.
  • The analysis involved 117 patients from the Czech Republic and the US, with results showing that age negatively impacted SGB success, while a higher left ventricular ejection fraction hinted at improved outcomes.
  • Overall, SGB was effective across different types of arrhythmias and cardiomyopathy causes, but elderly patients saw less benefit in arrhythmia suppression within 24 hours post-treatment.
View Article and Find Full Text PDF

The purpose of this study was to present a protocol for visualizing lymphatic flow in patients with heart failure (HF) by using indocyanine green fluorescence lymphography. We studied 37 subjects: 20 patients with acute heart failure (AHF) and lower limb edema, 7 patients with chronic heart failure (CHF) without lower limb edema, and 10 control subjects (no HF, no limb edema). All subjects were assessed at rest, and 11 subjects (6 control and 5 with CHF) were assessed again after a 10-minute walk.

View Article and Find Full Text PDF

The growth of digital health technology has led to innovative technological solutions that can help to improve patient care. However, the primary focus to date has been on the passive monitoring of patients, which poses difficulties in clinical integration and has not succeeded in optimizing care for chronic conditions. In this article, we highlight the move from a digital care model focused on the passive monitoring of medical conditions to one where holistic patient management is provided by dedicated external health care teams on a longitudinal basis.

View Article and Find Full Text PDF
Article Synopsis
  • * There is a pressing need to enhance clinical outcomes for heart failure patients by recognizing the limitations of current medical therapies and exploring new strategies.
  • * This review highlights ongoing research into innovative device-based therapies, like Cardiac Resynchronization Therapy and Left Ventricular Assist Devices, aimed at overcoming treatment challenges for heart failure patients.
View Article and Find Full Text PDF

Background: Anterior myocardial infarction standard of care prioritizes swift coronary reperfusion. Recent studies show left ventricular (LV) unloading with transvalvular axial flow pumps for 30 minutes before reperfusion (vs immediate reperfusion) decreases 28-day infarct size. Intra-aortic entrainment pumping, using hardware located away from the heart to provide support throughout the cardiac cycle, decreases effective systemic vascular resistance and augments visceral blood flow and pressure, and may reproduce this benefit with a decreased risk.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Marat Fudim"

  • - Marat Fudim's research primarily focuses on cardiovascular health, with special emphasis on heart failure (HF) and its related complications, highlighting the significance of understanding both physiological mechanisms and patient management strategies.
  • - His recent studies include exploring trends in coronary artery disease and obesity-related mortality, examining the role of the lymphatic system in HF's pathophysiology, and investigating advanced monitoring techniques and interventions for improving patient outcomes in heart failure.
  • - Fudim's work also incorporates innovative approaches, such as machine learning for HF prevention and the evaluation of novel devices for volume assessment, alongside analyzing baroreflex dysfunction's impact on cardiovascular diseases.